Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys
Tools
Tools
Tools
Morin, N, Morissette, M, Gregoire, L, Gomez-Mancilla, B, Gasparini, F and Di Paolo, T (2013) Chronic treatment with MPEP, an mGlu5 receptor antagonist, normalizes basal ganglia glutamate neurotransmission in L-DOPA-treated parkinsonian monkeys. NEUROPHARMACOLOGY. pp. 216-231.
Official URL: http://sfx.eu.novartis.net:9004/sfx_local?sid?url_...
| Item Type: | Article |
|---|---|
| Additional Information: | pubid: 47 nvp_institute: NIBR contributor_address: Laval Univ Med Ctr CHUQ, Neurosci Res Unit, Quebec City, PQ G1V 4G2, Canada, Univ Laval, Fac Pharm, Quebec City, PQ, Canada therese.dipaolo@crchul.ulaval.ca; Laval Univ Med Ctr CHUQ, Neurosci Res Unit, Quebec City, PQ G1V 4G2, Canada ; Novartis Inst BioMed Res, Basel, Switzerland ; Laval Univ Med Ctr CHUQ, Neurosci Res Unit, Quebec City, PQ G1V 4G2, Canada; Univ Laval, Fac Pharm, Quebec City, PQ, Canada; Di Paolo, T; Laval Univ Med Ctr CHUQ, Neurosci Res Unit, 2705 Laurier Blvd, Quebec City, PQ G1V 4G2, Canada |
| Date Deposited: | 13 Oct 2015 13:13 |
| Last Modified: | 13 Oct 2015 13:13 |
| URI: | https://oak.novartis.com/id/eprint/21895 |